The report provides a detailed analysis essential for establishing an Icosapent Ethyl production plant. It encompasses all critical aspects necessary for Icosapent Ethyl production, including the cost of Icosapent Ethyl production, Icosapent Ethyl plant cost, Icosapent Ethyl production costs, and the overall Icosapent Ethyl production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Icosapent Ethyl production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Icosapent ethyl is an omega-3 fatty acid medication used primarily to lower high triglyceride levels in the blood. It is widely used as a drug in the treatment of hypertriglyceridemia, which is a condition that can increase the risk of heart disease. Icosapent ethyl works by reducing the production of triglycerides in the liver, which can help prevent the buildup of fat in blood vessels and reduce the risk of heart disease. It finds its application in conjunction with lifestyle changes, such as a healthy diet and regular exercise, to manage cholesterol and reduce cardiovascular risks.
It is also sometimes prescribed to reduce the risk of heart attack and stroke in people with existing heart disease. Additionally, icosapent ethyl is also studied for its potential benefits in reducing the risk of heart attacks and stroke in patients with certain cardiovascular conditions.
The market for Icosapent Ethyl is predominantly led by its application as a prescription medication to treat patients with hypertriglyceridemia, which contributes to its demand in the medical sector. Its application as a medication in managing high triglyceride levels for reducing the risk of heart disease, stroke, and other cardiovascular complications largely contributes to its demand in the pharmaceutical industry. Its application in improving heart health by lowering triglycerides and reducing inflammation further accelerates its demand in the medical and healthcare sectors. Its involvement in combination therapies for patients at high risk of cardiovascular events further promotes its market growth.
The increasing global prevalence of cardiovascular diseases and the rising focus on preventive healthcare also drive the market for Icosapent ethyl. Several factors, such as the availability of raw materials, production costs, adherence to medical regulations, and maintaining quality standards, significantly influence industrial Icosapent ethyl procurement globally. Furthermore, advancements in drug formulation, improved supply chain management, and sustainable production practices also play a major role in shaping procurement strategies for Icosapent Ethyl.
Raw Material for Icosapent Ethyl Production
According to the Icosapent Ethyl production plant project report, the major raw materials for Icosapent Ethyl production include Fish Oil-Ethanol.
Manufacturing Process of Icosapent Ethyl
The extensive Icosapent Ethyl production cost report consists of the following industrial production process:
- Production via Esterification: The production process of Icosapent Ethyl begins with the ethyl esterification of fish oil, which involves reacting the oil with ethanol to form the ethyl ester of eicosapentaenoic acid (EPA). Further, multiple purification procedures are carried out to isolate the active substance. These steps mainly include rectification or distillation, followed by chromatography, which leads to the formation of highly purified Icosapent Ethyl active substance. The complete process results in the formation of pure Icosapent Ethyl, containing at least 96.0%. as the final product.
Icosapent ethyl is an ethyl ester of eicosapentaenoic acid (EPA), which is a type of omega-3 fatty acid. It appears as a white to off-white crystalline powder or a clear, colourless to pale yellow liquid. Its molecular formula is C22H32O2, and its molar mass is 328.5 g/mol. The compound has a density of approximately 0.91 g/cm³. Icosapent ethyl is soluble in ethanol and other organic solvents but is generally insoluble in water. It is administered in liquid form, and it remains stable under normal conditions. Icosapent ethyl is used as a prescription drug to lower triglyceride levels in the blood and reduce the risk of cardiovascular events. It is generally considered safe when used as directed, though side effects such as gastrointestinal discomfort may occur.